CardiaCare (זיו הלת'קר)
Tel Aviv-Yafo, Israel
CardiaCare has developed a wearable therapy for atrial fibrillation. CardiaCare's technology utilizes noninvasive peripheral neuromodulation to mediate a cardiovascular anti-arrhythmic response that reduces atrial fibrillation burden. The technology employs a closed-loop approach, involving monitoring and therapy. The wearable wrist-band combines advanced ECG and PPG sensors with AI-based treatment algorithms to induce a neuromodulation stimulus. CardiaCare's neuromodulation of the median and ulnar nerves balances sympathetic (stellate) and parasympathetic (vagus) tone via the brachial plexus. This induces a cardiovascular anti-arrhythmic response, reduces premature atrial contractions, modulates heart rate and rhythm, and reduces atrial fibrillation triggers and burden. CardiaCare is based on multiple clinical observations with neuromodulation therapy in patients with atrial fibrillation. CardiaCare has completed a technical and clinical proof of concept and secured its intellectual property.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2015
- Website
- my-cardiacare.com/
Categories
Only accessible to MedStartr community members.
Join nowWhat do you think of CardiaCare (זיו הלת'קר)?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now